Cardiff Oncology, Inc. Common Stock (CRDF) Stock Price, Quote & AI Analysis

Live CRDF stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Cardiff Oncology, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Cardiff Oncology, Inc. Common Stock (CRDF), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

CRDF
Cardiff Oncology, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
1.750000
High
1.760000
Low
1.660000
Volume
1,230,881
VWAP
-
Market Cap
$117,880,987.00
52W Range
$1.58 - $4.99
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 25, 2026 Q4
After Hours
EPS Estimate: $-0.1927
Revenue Estimate: $107,671.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Cardiff Oncology, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Cardiff Oncology, Inc. Common Stock Overview

Company information

Company Overview

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. The firm's clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

Company Details
Market Cap
$115.19M
Shares Outstanding
67,360,600
Weighted Shares Outstanding
67,360,564
CEO
Mani Mohindru
Address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Employees
33
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Cardiff Oncology, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...